Markets:

Overview

News

Currencies

International

Treasuries

Jazz Pharmaceuticals plc - Ordinary Shares (NQ:JAZZ)

139.15 +2.44 (+1.78%)

Streaming Delayed Price Updated: 9:45 AM EST, Nov 13, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Jazz Pharmaceuticals plc - Ordinary Shares

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

2 Top Growth Stocks to Buy Heading Into November ↗

October 30, 2021

There's plenty of growth on the horizon for these stocks, which are trading near their lows for the year.

Via The Motley Fool

Jim Cramer Considers nCino As Winner, Prefers This Stock Over Perficient ↗

October 27, 2021

On CNBC’s "Mad Money ...

Via Benzinga

Leading the Charge to Develop the First Orexin-Targeted Therapy to Address Narcolepsy at its Root Cause ↗

October 20, 2021

Photo by MART PRODUCTION from Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...

Via Benzinga

SEC Charges Former Goldman Sachs Officer For Insider Trading On 2 M&A Deals ↗

October 01, 2021

The Securities and Exchange Commission has charged a former Goldman Sachs (NYSE: GS) compliance analyst with using confidential information to generate over $...

Via Benzinga

Topics Regulatory Compliance

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight ↗

August 08, 2021

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...

Via Benzinga

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal ↗

October 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2021 ↗

October 05, 2021

Upgrades Wolfe Research upgraded the previous rating for PACCAR Inc (NASDAQ:

Via Benzinga

Needham Initiates Coverage With Buy For This Narcolepsy Player ↗

September 23, 2021

Needham

Via Benzinga

The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout ↗

October 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 4) Avadel Pharmaceuticals plc (...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 23, 2021 ↗

September 23, 2021

Upgrades Barclays upgraded the previous rating for Warner Music Group Corp (NASDAQ:

Via Benzinga

September Sell-Off: 3 Dirt Cheap Growth Stocks to Buy ↗

September 22, 2021

Get these stocks while they're near their 52-week lows.

Via The Motley Fool

The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs ↗

September 22, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Acceleron Pharma Inc. (...

Via Benzinga

Sales Of Three Major Pharmaceutical Cannabis Products Set To Reach €1.8 Billion By 2025 ↗

September 08, 2021

By Prohibition Partners Combined sales of the three most lucrative cannabis pharmaceuticals products - Epidiolex®, D...

Via Benzinga

Topics Cannabis

3 Biotech Stocks That Are Too Cheap to Ignore ↗

September 02, 2021

You'll definitely want to check out these biotech bargains.

Via The Motley Fool

The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold ↗

September 17, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 16) Bicycle Therapeutics plc (...

Via Benzinga

Attention Biotech Investors: Mark Your Calendar For September PDUFA Dates ↗

August 31, 2021

August proved to be a mixed month for regulatory approvals, with the Food and Drug Administration approving a few, turning down a few others and delaying the remaining. New...

Via Benzinga

Canada Approves Jazz Pharma's Excessive Daytime Sleepiness Med ↗

August 31, 2021

Health Canada has approved Jazz Pharmaceuticals plc's (NASDAQ: JAZZ) Sunosi (solriamfetol) for excessive daytime sleepiness (EDS) associated with narcolepsy or...

Via Benzinga

Got $4,000? Buy These 2 Cannabis-Focused Biotech Stocks ↗

August 31, 2021

Neither of them needs to sell marijuana to consumers to succeed.

Via The Motley Fool

Topics Cannabis

10 Small And Mid-Cap Growth Stocks To Buy Today ↗

August 18, 2021

If you are looking for long-term growth, you will most likely find it in small and mid-cap stocks because they have the room to grow. The bigger a company gets, the more difficult it is to achieve...

Via Talk Markets

This Cannabis Stock Is Full of Potential and Hasn't Been This Cheap in Months ↗

August 17, 2021

Investors have been selling off the stock since the company released its earnings report earlier this month.

Via The Motley Fool

Topics Cannabis

10 Biggest Price Target Changes For Monday ↗

August 16, 2021

UBS boosted the price target on Seagate Technology Holdings plc (NASDAQ:

Via Benzinga

The Week Ahead In Biotech: Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow ↗

August 15, 2021

Biopharma stocks retreated in the week ending Aug. 13, defying the optimism that was found in the broader market. Earnings continued to dominate the headlines, with small- and mid-cap companies among...

Via Talk Markets

Topics Initial Public Offering

The Week Ahead In Biotech (Aug. 15-21): Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow ↗

August 15, 2021

Biopharma stocks retreated in the week ending Aug. 13, defying the optimism that was found in the broader market. Earnings continued to dominate the headlines, with small-...

Via Benzinga

Topics Initial Public Offering

GW Pharmaceuticals' Cannabidiol For Seizures Wins UK Approval ↗

August 10, 2021

The U.K. Medicines and Healthcare Products Regulatory Agency (MHRA) has approved GW Pharmaceuticals' cannabidiol as an adjunctive treatment of seizures...

Via Benzinga

The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO ↗

August 13, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 12) Adagio Therapeutics, Inc. (...

Via Benzinga

The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma ↗

August 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (...

Via Benzinga

Watch Medical Marijuana & Unrivaled Brands At The Benzinga Cannabis Hour ↗

August 06, 2021

Benzinga’s Cannabis Hour is a live show for cannabis investors. On Thursday's show, hosts ...

Via Benzinga

Topics Cannabis

Cannabis Daily Podcast 8/5: Europe Expansion And Buy The Dip Opportunity Stocks ↗

August 05, 2021

Start The Day With The Best Daily Pre-Market Overview Of The Can...

Via Benzinga

Topics Cannabis

Innovators in Pharma Sectors See Potential, Promise in Providing Improved Treatments

August 05, 2021

Via FinancialNewsMedia

Jazz Pharmaceuticals PLC (JAZZ) Q2 2021 Earnings Call Transcript ↗

August 03, 2021

JAZZ earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.